Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2s, Hesperidin
2. 4h-1-benzopyran-4-one, 7-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (s)-
3. 7-rhamnoglucoside, Hesperetin
4. Hesperetin 7 Rhamnoglucoside
5. Hesperetin 7 Rutinoside
6. Hesperetin 7-rhamnoglucoside
7. Hesperetin-7-rutinoside
8. Hesperidin 2s
1. 520-26-3
2. Cirantin
3. Hesperidoside
4. Hesperetin 7-rhamnoglucoside
5. Hesperidine
6. Hesper Bitabs
7. Ciratin
8. (s)-(-)-hesperidin
9. Hesperetin 7-rutinoside
10. Nsc 44184
11. (2s)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-2,3-dihydrochromen-4-one
12. Hesperetin-7-rutinoside
13. Mls001304066
14. Hesperetin 7-o-rutinoside
15. Chebi:28775
16. Hesperitin-7-rhamnoglucoside
17. E750o06y6o
18. Hesperidin (jan)
19. (s)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)chroman-4-one
20. Hesperetin-rutinosid
21. Smr000718775
22. Hesperidin [jan]
23. Mfcd00075663
24. (2s)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2h-chromen-7-yl 6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside
25. (s)-7-[[6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4h-1-benzopyran-4-one
26. Aurantiamarin (methyl Hesperidin)
27. (2s)-hesperidin
28. (2s)-5-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chroman-4-one
29. (2s)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-3,4-dihydro-2h-1-benzopyran-4-one
30. Ccris 3940
31. Hesperitin-7-rutinoside
32. Sr-01000799145
33. Einecs 208-288-1
34. Brn 0075140
35. Unii-e750o06y6o
36. Hesperetin-7-o-rhamnoglucoside
37. Nsc-44184
38. Hesperidin,(s)
39. Ncgc00016481-01
40. (2s)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2h-chromen-7-yl 6-o-(6-deoxy-a-l-mannopyranosyl)-ss-d-glucopyranoside
41. (2s)-7-[[6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydro-4h-1-benzopyran-4-one (hesperidin)
42. (s)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(((2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yloxy)methyl)tetrahydro-2h-pyran-2-yloxy)chroman-4-one
43. Cas-520-26-3
44. C28h34o15
45. Diosvein
46. Hesperiden Powder
47. 3',5'-dihydroxy-4'-methoxy-7-rutinosyloxyflavan-4-on
48. Diosmin Ep Impurity B
49. Hesperidin, >=80%
50. Hesperidin [mi]
51. Diosmin [ndi]
52. Prestwick3_000400
53. Hesperidin [inci]
54. Hesperidin [vandf]
55. Ec 208-288-1
56. Glucopyranoside, Hesperetin-7 6-o-(6-deoxy-alpha-l-mannopyranosyl)-, Beta-d-
57. Hesperetin, 7-(6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside)
58. Hesperidin [mart.]
59. Dsstox_cid_24328
60. Dsstox_rid_80154
61. Hesperidin [usp-rs]
62. Hesperidin [who-dd]
63. Dsstox_gsid_44328
64. Schembl94586
65. Bspbio_000619
66. 4h-1-benzopyran-4-one, 7-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2,3-dihydo-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (s)-
67. 5-18-05-00218 (beilstein Handbook Reference)
68. 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-((6-o-alpha-l-rhamnopyranosyl-beta-d-glucopyranosyl)oxy)-4-chromanon
69. 7-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4h-1-benzopyran-4-one, (s)-
70. 7-(6-o-desoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyloxy)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-chromanon
71. Cid_10621
72. Hesperidin, Analytical Standard
73. Bpbio1_000681
74. Chembl449317
75. Ndi 590 [fdms]
76. Dtxsid9044328
77. Bcbcmap01_000136
78. Bdbm61776
79. 2h-pyran-2-yloxy)chroman-4-one
80. Hms2096o21
81. Hms2233i03
82. Hms3713o21
83. Zinc8143568
84. Tox21_110448
85. S2309
86. Akos015895450
87. Ccg-208580
88. Cs-5631
89. Db04703
90. Ks-5308
91. Smp1_000149
92. Ncgc00179501-01
93. 4h-1-benzopyran-4-one, 7-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (2s)-
94. Hy-15337
95. Ab00513829
96. H0049
97. C09755
98. D01038
99. (s)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-
100. Q385937
101. Hesperidin, Primary Pharmaceutical Reference Standard
102. Methyltetrahydro-2h-pyran-2-yloxy)methyl)tetrahydro-
103. Sr-01000799145-4
104. Sr-01000799145-5
105. Sr-01000799145-7
106. 7-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-
107. Brd-k38903228-001-02-8
108. Brd-k38903228-001-13-5
109. Hesperidin, European Pharmacopoeia (ep) Reference Standard
110. 3',5'-dihydroxy-4'-methoxy-7-rutinosyloxyflavan-4-one
111. Hesperetin 7-(6-o-alpha-l-rhamnopyranosyl)-beta-d-glucopyranoside
112. Hesperidin, Pharmaceutical Secondary Standard; Certified Reference Material
113. Flavanone, 3',5,7-trihydroxy-4'-methoxy-, 7-(6-o-alpha-l-rhamnosyl-d-glucoside)
114. (2s)-2-(4-methoxy-3-oxidanyl-phenyl)-7-[(2s,3r,4s,5s,6r)-6-[[(2r,3r,4r,5r,6s)-6-methyl-3,4,5-tris(oxidanyl)oxan-2-yl]oxymethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5-oxidanyl-2,3-dihydrochromen-4-one
115. (2s)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-[[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-2-oxanyl]oxymethyl]-2-oxanyl]oxy]-3,4-dihydro-2h-1-benzopyran-4-one
116. (2s)-7-((6-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl)oxy)-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4h-1-benzopyran-4-one
117. (s)-7-[[6-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4h-1-benzopyran-4-one
118. 4h-1-benzopyran-4-one, 7-((6-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl)oxy)-2,3-dihydo-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-, (s)-
119. 5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-((6-o-.alpha.-l-rhamnopyranosyl-.beta.-d-glucopyranosyl)oxy)-4-chromanon
| Molecular Weight | 610.6 g/mol |
|---|---|
| Molecular Formula | C28H34O15 |
| XLogP3 | -1.1 |
| Hydrogen Bond Donor Count | 8 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 7 |
| Exact Mass | 610.18977037 g/mol |
| Monoisotopic Mass | 610.18977037 g/mol |
| Topological Polar Surface Area | 234 Ų |
| Heavy Atom Count | 43 |
| Formal Charge | 0 |
| Complexity | 940 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 11 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27114
Submission : 2013-04-18
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26508
Submission : 2012-09-28
Status : Inactive
Type : II
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 722
Submission : 1963-11-05
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
Basic Nutrition, your expert for sourcing from China, India and Europe.
About the Company : As an ISO9001, ISO22000 certificated supplier, Basic Nutrition supply high-quality ingredients for nutraceuticals. We can offer a range of products from small to large quantites: h...
About the Company : Chengdu Chen Green Biotechnology (Chen Green) is a company specializing in plant extracts, pharmaceutical raw materials, food additives and dietary supplements manufacturers and wh...
About the Company : Chengdu Yazhong Bio-pharmaceutical Co., Ltd., founded in 2002, is a leading company with plant extracts, APIs and medical intermediates. Our company is equipped with GMP approved m...
About the Company : HTBA (HealthTech BioActives), a global company specialized in flavonoids and vitamin B12 derivatives, with over 40 years of experience in natural-origin pharmaceutical ingredients....
About the Company : Hunan Bitian Technology Co.,Ltd is dedicate to R&D, Manufacturing and Distribution of Natural Ingredients, Natural Colors, Natrual Fruit & Vegetable Powder, Cosmetic Materials and ...
About the Company : Mianyang Di'ao Pharma is specialized in Citrus products since its founding in 1994, with an aim to bringing the best Citrus products for human health, we have been focusing on Citr...
About the Company : Benepure is a global research, manufacture and supplier of ingredients and their derivatives for healthcare industry. It owns strong research and development team, cutting-edge equ...
About the Company : Founded in 1980, Sichuan Xieli Pharmaceutical Co., Ltd. operates with the guiding principle of "collaborating to build a healthy enterprise." The company specializes in the cultiva...
About the Company : Wuhan Sun-shine chemical Corporation Limited (Shanghai Sun-shine Chemical Technology Corporation Limited) is a high-tech enterprise engaged inR&D and sales of related compounds of ...
About the Company : Since 2008, Sunriver Biotech has been a leader in the research and utilizing plant resources for people’s well-being and quality of life.Through 12 years development, Sunriver Bi...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
Details:
Hesperidin is a dietary supplement drug, which is currently being evaluated in clinical studies for the treatment of multiple sclerosis.
Lead Product(s): Hesperidin,Inapplicable
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Dietary Supplement
Sponsor: BioActor
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 05, 2026
Lead Product(s) : Hesperidin,Inapplicable
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : BioActor
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Hesperidin is a dietary supplement drug, which is currently being evaluated in clinical studies for the treatment of multiple sclerosis.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
March 05, 2026
Details:
Diosmin is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Undisclosed clinical studies for the treatment of Venous Insufficiency.
Lead Product(s): Diosmin,Hesperidin,Bromelain,Ruscus Aculeatus
Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 22, 2025
Lead Product(s) : Diosmin,Hesperidin,Bromelain,Ruscus Aculeatus
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Diosmin is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Undisclosed clinical studies for the treatment of Venous Insufficiency.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 22, 2025
Details:
Diosmin is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Lead Product(s): Diosmin,Hesperidin
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable December 15, 2021
Lead Product(s) : Diosmin,Hesperidin
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioavailability of Diosmin/Hesperidin (90/10) 500 mg Tablets With Regards to Reference Product
Details : Diosmin is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 15, 2021
Details:
Montreal Heart Institute study to evaluate the ability of hesperidin, the medicinal ingredient in Hesperco™ capsules, to reduce the severity of symptoms and the need for hospitalization in COVID-19 patients.
Lead Product(s): Hesperidin,Inapplicable
Therapeutic Area: Infections and Infectious Diseases Brand Name: Hesperco
Study Phase: Phase IIProduct Type: Dietary Supplement
Sponsor: Ingenew Pharma
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable February 17, 2021
Lead Product(s) : Hesperidin,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Ingenew Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Valeo Pharma's Hesperco™ Capsules at the Core of Montreal Heart Institute's Hesperidin Coronavir...
Details : Montreal Heart Institute study to evaluate the ability of hesperidin, the medicinal ingredient in Hesperco™ capsules, to reduce the severity of symptoms and the need for hospitalization in COVID-19 patients.
Product Name : Hesperco
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
February 17, 2021
Details:
Hesperidin is a Dietary Supplement drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of COVID-19.
Lead Product(s): Hesperidin,Inapplicable
Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Dietary Supplement
Sponsor: Ingenew Pharmaceuticals Inc.
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 20, 2021
Lead Product(s) : Hesperidin,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : Ingenew Pharmaceuticals Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN)
Details : Hesperidin is a Dietary Supplement drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
January 20, 2021
Details:
Valeo Pharma has filed for a Natural Product Licence with Health Canada for its unique bioflavonoid formulation, HespercoTM. HespercoTM capsules contain a powerful antioxidant that can be taken for immune system support.
Lead Product(s): Hesperidin,Inapplicable
Therapeutic Area: Infections and Infectious Diseases Brand Name: HesperCo
Study Phase: UndisclosedProduct Type: Dietary Supplement
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable August 24, 2020
Lead Product(s) : Hesperidin,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Valeo Pharma has filed for a Natural Product Licence with Health Canada for its unique bioflavonoid formulation, HespercoTM. HespercoTM capsules contain a powerful antioxidant that can be taken for immune system support.
Product Name : HesperCo
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
August 24, 2020
Details:
Meal Replacement Shake is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Lead Product(s): Meal Replacement Shake,Multivitamin,Mineral,Fish Oil,Sesame Lignans,Olive Extract,Prebiotic,Clove Extract,Maqui Berry Extract,Whole Food Blend,Curcumin,European White Kidney Bean,Saffron Extract,Coenzyme Q10,Fulvic Acid,Calcium,Hesperidin,Gynostemma Extract
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Dietary Supplement
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable December 13, 2017
Lead Product(s) : Fish Oil, Curcumin, Saffron Extract, Coenzyme Q10, Calcium
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Meal Replacement Shake is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
December 13, 2017
Details:
Hesperidin is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Osteoporosis, Postmenopausal.
Lead Product(s): Hesperidin,Calcilock
Therapeutic Area: Musculoskeletal Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Dietary Supplement
Sponsor: Nestec
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable June 19, 2013
Lead Product(s) : Hesperidin,Calcilock
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Nestec
Deal Size : Inapplicable
Deal Type : Inapplicable
Hesperidin and Bone Health in Postmenopausal Women
Details : Hesperidin is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Osteoporosis, Postmenopausal.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
June 19, 2013
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
Others
Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.
CAS Number : 520-26-3
Quantity Per Vial :
Sale Unit :
Price : $208.00
Details :
Monograph : PHR1794-500MG
Storage : +2°C to +8°C
Code/Batch No :
CAS Number : 24292-52-2
Quantity Per Vial :
Sale Unit :
Price :
Details : In stock
Monograph :
Storage :
Code/Batch No : H0069.00
CAS Number : 520-26-3
Quantity Per Vial : 20 MG
Sale Unit :
Price : Euro 250
Details : Purity > 98.0 %
Monograph :
Storage :
Code/Batch No : 7500741
CAS Number : 520-26-3
Quantity Per Vial : 50 MG
Sale Unit :
Price : Euro 350
Details : Purity > 98.0 %
Monograph :
Storage :
Code/Batch No : 7500741
CAS Number : 64726-90-5
Quantity Per Vial : 200
Sale Unit : mg
Price : $220.00
Details : Material Origin- Plant; USMCA- No; KORUS- No
Monograph :
Storage :
Code/Batch No : Catalog #1304377 / R09140
CAS Number :
Quantity Per Vial :
Sale Unit :
Price : $208.00
Details :
Monograph : PHR1794-500MG
Storage : +2?C to +8?C
Code/Batch No :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ANALYTICAL
Analytical Methods
Product Code : JH08S04-1546WT
Classification : Natural products
Product Characteristics : A970506A
Category :
Description :
Product Code : AS12S05-1546WT
Classification : Natural products
Product Characteristics : A970430A
Category :
Description :
ABOUT THIS PAGE
45
PharmaCompass offers a list of Hesperidin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Hesperidin manufacturer or Hesperidin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Hesperidin manufacturer or Hesperidin supplier.
PharmaCompass also assists you with knowing the Hesperidin API Price utilized in the formulation of products. Hesperidin API Price is not always fixed or binding as the Hesperidin Price is obtained through a variety of data sources. The Hesperidin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A MolPort-001-794-015 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of MolPort-001-794-015, including repackagers and relabelers. The FDA regulates MolPort-001-794-015 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. MolPort-001-794-015 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of MolPort-001-794-015 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A MolPort-001-794-015 supplier is an individual or a company that provides MolPort-001-794-015 active pharmaceutical ingredient (API) or MolPort-001-794-015 finished formulations upon request. The MolPort-001-794-015 suppliers may include MolPort-001-794-015 API manufacturers, exporters, distributors and traders.
click here to find a list of MolPort-001-794-015 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A MolPort-001-794-015 DMF (Drug Master File) is a document detailing the whole manufacturing process of MolPort-001-794-015 active pharmaceutical ingredient (API) in detail. Different forms of MolPort-001-794-015 DMFs exist exist since differing nations have different regulations, such as MolPort-001-794-015 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A MolPort-001-794-015 DMF submitted to regulatory agencies in the US is known as a USDMF. MolPort-001-794-015 USDMF includes data on MolPort-001-794-015's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The MolPort-001-794-015 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of MolPort-001-794-015 suppliers with USDMF on PharmaCompass.
MolPort-001-794-015 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of MolPort-001-794-015 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right MolPort-001-794-015 GMP manufacturer or MolPort-001-794-015 GMP API supplier for your needs.
A MolPort-001-794-015 CoA (Certificate of Analysis) is a formal document that attests to MolPort-001-794-015's compliance with MolPort-001-794-015 specifications and serves as a tool for batch-level quality control.
MolPort-001-794-015 CoA mostly includes findings from lab analyses of a specific batch. For each MolPort-001-794-015 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
MolPort-001-794-015 may be tested according to a variety of international standards, such as European Pharmacopoeia (MolPort-001-794-015 EP), MolPort-001-794-015 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (MolPort-001-794-015 USP).
